🇺🇸 FDA
Patent

US 7250169

Anti-tumor activity of Ea-4-peptide of pro-IGF-1

granted A61KA61K31/711A61K38/30

Quick answer

US patent 7250169 (Anti-tumor activity of Ea-4-peptide of pro-IGF-1) held by UNIVERSITY OF CONNECTICUT expires Mon Jul 26 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
UNIVERSITY OF CONNECTICUT
Grant date
Tue Jul 31 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 26 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K31/711, A61K38/30, A61P, A61P35/00